New registry tracks young brain tumor patients to boost research
NCT ID NCT02238899
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This registry collected information and biological samples from 354 children and young adults diagnosed with certain brain tumors like medulloblastoma and ependymoma. The goal was to improve diagnostic standards through expert review and to gather data for future research. No new treatment was tested; instead, the focus was on understanding the disease better.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CENTRAL NERVOUS SYSTEM PRIMITIVE NEUROECTODERMAL TUMOR are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University Hospital
Hamburg, 20246, Germany
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can trained immune cells outsmart brain tumors?
- New platform trial takes on NF2 tumors with multiple drug strategies
- Could a cancer drug shrink brain tumors and save hearing in a rare nerve disorder?
- AI reads MRI scans to reveal hidden brain tumor types in children before surgery
- Targeted radiation zaps childhood brain tumors in early trial
- Brain tumor study probes how income and community shape health